Mark Creamer, Richard Bryant, Amy Lehrner, Barbara O Rothbaum, Josef I Ruzek, Paula P Schnurr
{"title":"利用致幻剂治疗创伤后应激障碍:科学支持所有的炒作吗?","authors":"Mark Creamer, Richard Bryant, Amy Lehrner, Barbara O Rothbaum, Josef I Ruzek, Paula P Schnurr","doi":"10.1002/jts.23163","DOIUrl":null,"url":null,"abstract":"<p><p>This paper is an edited transcript of a plenary panel held at the 2024 Annual Meeting of the International Society for Traumatic Stress Studies (ISTSS) in Boston, Massachusetts, United States. The panel comprised Drs. Mark Creamer (moderator), Richard Bryant (convenor), Amy Lehrner, Barbara O. Rothbaum, Joseph I. Ruzek, and Paula P. Schnurr. Bringing together clinicians and researchers with a diverse range of views, the panel sought to explore some of the pressing issues confronting the field. Following opening comments, the discussion addressed topics such as: \"What is covered under the rubric of 'psychedelics'?,\" \"Is there too much hype?,\" \"What is the role of psychotherapy?,\" \"What are the putative mechanisms of change?,\" and \"What are the key ethical issues?\" Audience questions were followed by brief closing comments. Despite disagreements, there was a high level of consensus that psychedelic-assisted psychotherapy represents an exciting possibility for people living with posttraumatic stress disorder who have not responded to existing evidence-based treatments. Equally, there was agreement that considerably more rigorous research is required before definitive conclusions can be drawn regarding the specific components and efficacy of these approaches. Ethical concerns, particularly regarding accessibility, will present a significant challenge for provider organizations.</p>","PeriodicalId":17519,"journal":{"name":"Journal of traumatic stress","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Harnessing psychedelics for treating posttraumatic stress disorder: Does the science support all the hype?\",\"authors\":\"Mark Creamer, Richard Bryant, Amy Lehrner, Barbara O Rothbaum, Josef I Ruzek, Paula P Schnurr\",\"doi\":\"10.1002/jts.23163\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This paper is an edited transcript of a plenary panel held at the 2024 Annual Meeting of the International Society for Traumatic Stress Studies (ISTSS) in Boston, Massachusetts, United States. The panel comprised Drs. Mark Creamer (moderator), Richard Bryant (convenor), Amy Lehrner, Barbara O. Rothbaum, Joseph I. Ruzek, and Paula P. Schnurr. Bringing together clinicians and researchers with a diverse range of views, the panel sought to explore some of the pressing issues confronting the field. Following opening comments, the discussion addressed topics such as: \\\"What is covered under the rubric of 'psychedelics'?,\\\" \\\"Is there too much hype?,\\\" \\\"What is the role of psychotherapy?,\\\" \\\"What are the putative mechanisms of change?,\\\" and \\\"What are the key ethical issues?\\\" Audience questions were followed by brief closing comments. Despite disagreements, there was a high level of consensus that psychedelic-assisted psychotherapy represents an exciting possibility for people living with posttraumatic stress disorder who have not responded to existing evidence-based treatments. Equally, there was agreement that considerably more rigorous research is required before definitive conclusions can be drawn regarding the specific components and efficacy of these approaches. Ethical concerns, particularly regarding accessibility, will present a significant challenge for provider organizations.</p>\",\"PeriodicalId\":17519,\"journal\":{\"name\":\"Journal of traumatic stress\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of traumatic stress\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/jts.23163\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of traumatic stress","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jts.23163","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
摘要
这篇论文是在美国马萨诸塞州波士顿举行的国际创伤应激研究学会(ISTSS) 2024年年会上举行的全体会议的编辑记录。小组成员包括博士。Mark Creamer(主持人),Richard Bryant(召集人),Amy Lehrner, Barbara O. Rothbaum, Joseph I. Ruzek和Paula P. Schnurr。该小组汇集了临床医生和研究人员的不同观点,试图探讨该领域面临的一些紧迫问题。在开场评论之后,讨论的主题是:“‘迷幻药’的标题涵盖了什么?,“是不是有太多的炒作?”、“心理治疗的作用是什么?”“什么是假定的变化机制?”、“关键的伦理问题是什么?”听众提问之后是简短的总结。尽管存在分歧,但高度一致认为,迷幻辅助心理治疗为那些对现有循证治疗没有反应的创伤后应激障碍患者提供了一种令人兴奋的可能性。同样,与会者一致认为,在就这些办法的具体组成部分和功效得出明确结论之前,需要进行相当严格的研究。伦理问题,特别是关于可访问性,将对提供者组织提出重大挑战。
Harnessing psychedelics for treating posttraumatic stress disorder: Does the science support all the hype?
This paper is an edited transcript of a plenary panel held at the 2024 Annual Meeting of the International Society for Traumatic Stress Studies (ISTSS) in Boston, Massachusetts, United States. The panel comprised Drs. Mark Creamer (moderator), Richard Bryant (convenor), Amy Lehrner, Barbara O. Rothbaum, Joseph I. Ruzek, and Paula P. Schnurr. Bringing together clinicians and researchers with a diverse range of views, the panel sought to explore some of the pressing issues confronting the field. Following opening comments, the discussion addressed topics such as: "What is covered under the rubric of 'psychedelics'?," "Is there too much hype?," "What is the role of psychotherapy?," "What are the putative mechanisms of change?," and "What are the key ethical issues?" Audience questions were followed by brief closing comments. Despite disagreements, there was a high level of consensus that psychedelic-assisted psychotherapy represents an exciting possibility for people living with posttraumatic stress disorder who have not responded to existing evidence-based treatments. Equally, there was agreement that considerably more rigorous research is required before definitive conclusions can be drawn regarding the specific components and efficacy of these approaches. Ethical concerns, particularly regarding accessibility, will present a significant challenge for provider organizations.
期刊介绍:
Journal of Traumatic Stress (JTS) is published for the International Society for Traumatic Stress Studies. Journal of Traumatic Stress , the official publication for the International Society for Traumatic Stress Studies, is an interdisciplinary forum for the publication of peer-reviewed original papers on biopsychosocial aspects of trauma. Papers focus on theoretical formulations, research, treatment, prevention education/training, and legal and policy concerns. Journal of Traumatic Stress serves as a primary reference for professionals who study and treat people exposed to highly stressful and traumatic events (directly or through their occupational roles), such as war, disaster, accident, violence or abuse (criminal or familial), hostage-taking, or life-threatening illness. The journal publishes original articles, brief reports, review papers, commentaries, and, from time to time, special issues devoted to a single topic.